1 option
Coronavirus disease 2019 (COVID-19) emergency use authorizations (EUAs) / United States Food and Drug Administration.
- Format:
- Journal/Periodical
- Author/Creator:
- United States Food and Drug Administration, author, issuing body.
- Language:
- English
- Subjects (All):
- COVID-19 (Disease)--Chemotherapy.
- COVID-19 (Disease).
- Physical Description:
- 1 online resource
- annual
- Began with: 2021-
- Other Title:
- Coronavirus disease 2019
- Place of Publication:
- Silver Spring, MD : Food and Drug Administration, 2021.
- Contents:
- Vaccines
- Last Update: June 15, 2023.
- COVID-19 Vaccines
- Convalescent Plasma
- Novavax Decision Memorandum - July 13, 2022 - References
- Novavax Decision Memorandum - October 19, 2022 - References
- Janssen Decision Memorandum - February 4, 2021 - References
- Janseen - Memorandum to the file - October 4, 2021 - References
- Moderna Decision Memorandum - November 30, 2020 - References
- Moderna Review Memorandum - September 3, 2021 - References
- Moderna Decision Memorandum - October 20, 2021 - References
- Moderna Decision Memorandum - June 17, 2022 - References
- Moderna Decision Memorandum - August 31, 2022 - References
- Moderna Decision Memorandum - April 18, 2023 - References
- Pfizer Decision Memorandum - December 2020 - References
- Pfizer Decision Memorandum - May 2021 - References
- Pfizer Decision Memorandum - September 24, 2021 - References
- Pfizer Decision Memorandum - October 29, 2021 - References
- Pfizer Decision Memorandum - May 17, 2022 - References
- Pfizer Decision Memorandum - June 17, 2022 - References
- Pfizer Decision Memorandum - August 31, 2022 - References
- Pfizer Decision Memorandum - October 2022 - References
- Pfizer Decision Memorandum - December 2022 - References
- Pfizer Decision Memorandum - March 2023 - References
- Pfizer Decision Memorandum - April 18, 2023 - References
- Emergency Use Authorization (EUA) Amendment for an Unapproved Product Review Memorandum References
- Drug and Biological Therapeutic Products
- Last Update: April 10, 2024.
- EUAs for CDER-regulated Products
- COVID-19 Convalescent Plasma Clinical Memorandum December 27, 2021 - References
- COVID-19 convalescent plasma Decision Memorandum References
- Medical Devices
- Last Update: April 15, 2024.
- Blood Purification Devices EUAs
- Continuous Renal Replacement Therapy and Hemodialysis Devices EUAs
- In Vitro Diagnostics EUAs
- Infusion Pump EUAs
- Personal Protective Equipment EUAs
- Withdrawal Due to Other Reasons
- Remote or Wearable Patient Monitoring Devices EUAs
- Respiratory Assist Devices EUAs
- Ventilators and Ventilator Accessories EUAs
- Other Medical Device EUAs.
- Notes:
- Description based on publisher supplied metadata and other sources.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.